HB 222

Maryland House of Delegates bill in Session 2026.

Status: enrolled. Latest action: May 24, 2026.

County Boards of Education - Opioid Overdose-Reversing Medications - Policy Requirements (Naloxone Access Act).

Bill ID MD-2026-HB-222

Session 2026

Status enrolled

Committee Ways and Means; Appropriations; Education, Energy, and the Environment

House of Delegates enrolled 2026-05-24

Drug / Cannabis Policy Education

Summary

Requiring each county board of education to update certain policies to include information on authorized possession of naloxone or other opioid overdose-reversing medication by certain high school students and immunity from liability; and altering the list of individuals who may administer naloxone or other opioid overdose-reversing medication under a certain policy.

Sponsor

Delegate Vogel

Official Source Back to Bills

Actions Timeline

Date	Event	Detail
2026-01-14	Introduced	Bill introduced
2026-05-24	Status	enrolled
2026-05-24	Latest Action	In the Senate - Third Reading Passed with Amendments (31-6)

More Bills From This Sponsor

HB 144

Commercial Law – Fair Pricing and Market Competition Fund – Establishment

introduced • House of Delegates

HB 148

Consumer Protection and Labor and Employment - Surveillance-Based Price and Wage Setting - Prohibition

introduced • House of Delegates

HB 151

Sales and Use Tax - Distribution of Cannabis Sales Tax Revenue - Maryland Veterans Trust Fund

introduced • House of Delegates

HB 168

Housing and Community Development - Affordable Housing - Educator Workforce Housing and Municipal Corporations

enrolled • House of Delegates

HB 179

Department of Commerce - Complaint Portal and Annual Report

introduced • House of Delegates

HB 202

Public Health - Social Isolation and Loneliness Pilot Grant Program - Establishment

introduced • House of Delegates